Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department

Annals of Allergy, Asthma and Immunology

Volumn 103, Issue 6, 2009, Pages 502-507

  Bluestein, Hazel M ^a   Hoover, Todd A ^b   Banerji, Aleena Suryadevara ^c   Camargo Jr , Carlos A ^c   Reshef, Avner ^d   Herscu, Paul ^b  

^a Victim Serv Ctr of Montgomery Co   (United States)

^b Herscu Laboratory   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CLOPIDOGREL; CORTICOSTEROID; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; ENALAPRIL; FAMOTIDINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; LISINOPRIL; LOOP DIURETIC AGENT; METHYLPREDNISOLONE; RAMIPRIL; SALBUTAMOL; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL;

ADULT; AGED; ALLERGY; AMBULANCE; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CLINICAL FEATURE; COMMUNITY HOSPITAL; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMERGENCY WARD; FEMALE; HISTORY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MALE; MEDICAL RECORD REVIEW; MORBIDITY; PRIORITY JOURNAL; PRURITUS; SYMPTOM; TERTIARY HEALTH CARE; URTICARIA;

EID: 74749088316     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60267-0     Document Type: Article

References (25)

1. Williams GH. Converting-enzyme inhibitors in the treatment of hypertension. N Engl J Med. 1988;319:1517-1525.
2. Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316: 1429-1435.
3. Studies of Left Ventricular Dysfunction (SOLVD) Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
4. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456-1462.
5. Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342: 821-828.
6. Pfeffer MA, Braunwald E, Moye LA, et al; SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669-677.
7. Smith RE, Ashiya M. Antihypertensive therapies. Nat Rev Drug Discov. 2007;6:597-598.
8. IMS National Prescription Audit PLUS. Top therapeutic classes by U.S. dispensed prescriptions. http://www.imshealth.com/deployedfiles/ imshealth/Global/Content/StaticFile/Top-Line-Data/2008-Top-Therapy- Classes-By-U.S.-RX.pdf. Accessed August 26, 2008.
9. Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P. Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors [published online ahead of print July 29, 2009]. Clin Exp Allergy. doi:10.1111/j.1365-2222.2009. 03323.x.
10. Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165: 1637-1642.
11. Dyer PD. Late-onset angioedema after interruption of angiotensin converting enzyme inhibitor therapy. J Allergy Clin Immunol. 1994;93: 947-948.
12. Roberts DS, Mahoney EJ, Hutchinson CT, Aliphas A, Grundfast KM. Analysis of recurrent angiotensin converting enzyme inhibitor-induced angioedema. Laryngoscope. 2008;118:2115-2120.
13. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008;100:327-332.
14. Agah R, Bandi V, Guntupalli KK. Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med. 1997;23:793-796.
15. Megerian CA, Arnold JE, Berger M. Angioedema: 5 years' experience, with a review of the disorder's presentation and treatment. Laryngoscope. 1992;102:256-260.
16. Pigman EC, Scott JL. Angioedema in the emergency department: the impact of angiotensin-converting enzyme inhibitors. Am J Emerg Med. 1993;11:350-354.
17. Gabb GM, Ryan P, Wing LM, Hutchinson KA. Epidemiological study of angioedema and ACE inhibitors. Aust N Z J Med. 1996;26:777-782.
18. Lin RY, Shah SN. Increasing hospitalizations due to angioedema in the United States. Ann Allergy Asthma Immunol. 2008;101:185-192.
19. McDowell SE, Coleman JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006;332:1177-1181.
20. Banerji A, Oren E, Hesterberg P, Hsu Y, Camargo CA Jr, Wong JT. Ten-year study of causes of moderate to severe angioedema seen by an inpatient allergy/immunology consult service. Allergy Asthma Proc. 2008;29:88-92.
21. Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffre D, Nussberger J. Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology. 1999;44:21-25.
22. Burkhart DG, Brown NJ, Griffin MR, Ray WA, Hammerstrom T, Weiss S. Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites. Pharmacoepidemiol Drug Saf. 1996; 5:149-154.
23. Agostoni A, Aygoren-Pursun E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114:S51-S131.
24. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med. 2004;164: 910-913.
25. Warner K, Visconti J, Tschampel M. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Ann Pharmacother. 2000;34:526 -528.